News . Data . Research
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health conditions. The
Veeva Systems Inc. (NYSE: VEEV) Q3 2021 earnings call dated Dec. 01, 2020 Corporate Participants: Ato Garrett -- Senior Director, Investor Relations Peter Gassner -- Founder,
Shares of AdaptHealth Corp. (NASDAQ: AHCO) surged 15% in morning trade on Tuesday after the company announced its decision to acquire privately-held
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) Q3 2020 earnings call dated Nov. 25, 2020. Corporate Participants: Philip Lisio -- Investor Relations, The Foote
Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown in the
Medtronic PLC (NYSE: MDT) Q2 2021 earnings call dated Nov. 24, 2020 Corporate Participants: Ryan Weispfenning -- Vice President - Head of Investor Relations
Medtronic plc (NYSE: MDT) reported second quarter 2021 earnings results today. Worldwide revenue was $7.64 billion, down 0.8% on a reported basis
Agilent Technologies Inc. (NYSE: A) Q4 2020 earnings call dated Nov. 23, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor Relations Mike
The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for the development
10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went public more
Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
Palatin Technologies, Inc. (AMEX: PTN) Q1 2021 earnings call dated Nov. 17, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer Stephen
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their COVID vaccine
Shares of Moderna Inc. (NASDAQ: MRNA) were up over 8% in morning trade on Monday as the company reported positive results from
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q3 2020 earnings call dated Nov. 13, 2020 Corporate Participants: Will O'Connor -- Stern Investor Relations Peter Nielsen -- President, Chief
Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss -- Investor Relations Michael W. Nall -- President and Chief
Shares of Beyond Air Inc. (NASDAQ: XAIR) gained over 3% in midday trade on Thursday. The stock has climbed 5% since the
PDL BioPharma, Inc. (NASDAQ: PDLI) Q3 2020 earnings call dated Nov. 11, 2020 Corporate Participants: Jody Cain -- Senior Vice President, LHA Dominique Monnet -- President
Beyond Air, Inc. (NASDAQ: XAIR) Q2 2021 earnings call dated Nov. 11, 2020 Corporate Participants: Maria Yonkoski -- Head of Investor Relations Steve Lisi -- Chief
The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA issued a